Title:
PHARMACEUTICAL COMPOSITION FOR TREATING TUMORS
Document Type and Number:
WIPO Patent Application WO/2022/092085
Kind Code:
A1
Abstract:
Provided is a pharmaceutical composition for treating tumors which is administered in combination with a PD-1 antagonist and contains 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmaceutically acceptable salt thereof.
Inventors:
HOSHI TAISUKE (JP)
KATO YU (JP)
OZAWA YOICHI (JP)
KAWANO SATOSHI (JP)
KODAMA KOTARO (JP)
WATANABE SAORI (JP)
KATO YU (JP)
OZAWA YOICHI (JP)
KAWANO SATOSHI (JP)
KODAMA KOTARO (JP)
WATANABE SAORI (JP)
Application Number:
PCT/JP2021/039490
Publication Date:
May 05, 2022
Filing Date:
October 26, 2021
Export Citation:
Assignee:
EISAI R&D MAN CO LTD (JP)
International Classes:
A61K31/4545; A61K39/395; A61K45/00; A61P15/00; A61P35/00; A61P35/04; A61P43/00
Domestic Patent References:
| WO2017104739A1 | 2017-06-22 | |||
| WO2019189241A1 | 2019-10-03 | |||
| WO2019189241A1 | 2019-10-03 | |||
| WO2004004771A1 | 2004-01-15 | |||
| WO2004072286A1 | 2004-08-26 | |||
| WO2004056875A1 | 2004-07-08 |
Foreign References:
| JP2018512391A | 2018-05-17 | |||
| JP2018507220A | 2018-03-15 | |||
| JP2018538274A | 2018-12-27 | |||
| US20140235614A1 | 2014-08-21 | |||
| US20180015079A1 | 2018-01-18 | |||
| US20180303817A1 | 2018-10-25 | |||
| US20170217935A1 | 2017-08-03 | |||
| US7488802B2 | 2009-02-10 | |||
| US7521051B2 | 2009-04-21 | |||
| US8008449B2 | 2011-08-30 | |||
| US8354509B2 | 2013-01-15 | |||
| US8168757B2 | 2012-05-01 | |||
| US20110271358A1 | 2011-11-03 |
Other References:
THE JOURNAL OF CLINICAL INVESTIGATION, vol. 125, no. 9, September 2015 (2015-09-01)
"Japanese Pharmacopoeia"
"Japanese Pharmacopoeia"
Attorney, Agent or Firm:
HASEGAWA Yoshiki et al. (JP)
Download PDF:
Previous Patent: FUSED HETEROCYCLE DERIVATIVE AND HERBICIDE CONTAINING SAME AS ACTIVE INGREDIENT
Next Patent: EXHAUST GAS TREATMENT FACILITY
Next Patent: EXHAUST GAS TREATMENT FACILITY